AVNET, SOFIA
 Distribuzione geografica
Continente #
NA - Nord America 5.520
EU - Europa 3.955
AS - Asia 1.981
AF - Africa 215
OC - Oceania 30
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.716
Nazione #
US - Stati Uniti d'America 5.390
GB - Regno Unito 1.051
CN - Cina 685
DE - Germania 655
SG - Singapore 569
IT - Italia 561
SE - Svezia 521
VN - Vietnam 394
IN - India 209
UA - Ucraina 203
IE - Irlanda 171
RU - Federazione Russa 171
FR - Francia 160
CA - Canada 129
AT - Austria 88
ZA - Sudafrica 75
TG - Togo 70
CH - Svizzera 68
FI - Finlandia 67
EE - Estonia 64
BG - Bulgaria 52
CI - Costa d'Avorio 46
JO - Giordania 32
AU - Australia 29
BE - Belgio 25
ID - Indonesia 23
JP - Giappone 23
NL - Olanda 20
GR - Grecia 18
HK - Hong Kong 15
SC - Seychelles 15
LT - Lituania 13
ES - Italia 11
PL - Polonia 9
BR - Brasile 6
DK - Danimarca 6
KR - Corea 6
CL - Cile 5
IR - Iran 5
LB - Libano 5
CZ - Repubblica Ceca 4
HR - Croazia 4
NG - Nigeria 4
RO - Romania 4
TR - Turchia 4
EG - Egitto 3
HU - Ungheria 3
BD - Bangladesh 2
MY - Malesia 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
IQ - Iraq 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TW - Taiwan 1
Totale 11.716
Città #
Southend 816
Fairfield 600
Chandler 535
Singapore 516
Santa Clara 420
Ashburn 375
Woodbridge 314
Wilmington 296
Ann Arbor 280
Seattle 274
Houston 248
Princeton 234
Dong Ket 212
Cambridge 189
Dublin 170
Boardman 149
Jacksonville 132
Munich 100
Bologna 94
Westminster 86
Nanjing 82
Padova 79
Mcallen 77
Montréal 74
Lomé 70
Berlin 65
Bern 63
Vienna 59
Helsinki 57
Saint Petersburg 55
Sofia 52
Jinan 51
San Diego 47
Abidjan 46
Beijing 37
Shenyang 36
Hebei 34
Milan 34
Amman 32
Medford 30
Mülheim 29
Nanchang 29
Ottawa 29
Florence 28
Turin 28
Bremen 27
Brussels 25
Des Moines 25
Guangzhou 25
Brisbane 23
Jakarta 23
Zhengzhou 22
Changsha 21
Tianjin 21
New York 20
Norwalk 18
Shanghai 18
Redmond 17
Toronto 17
Kuban 16
Wuhan 16
Mahé 15
Olalla 15
Jiaxing 14
Tokyo 14
Hong Kong 13
Phoenix 13
Haikou 12
London 12
Moscow 12
Paris 12
Pune 12
Redwood City 12
Fremont 11
Braunschweig 10
Hangzhou 10
Lanzhou 10
Rimini 10
Taizhou 10
Andover 9
Bühl 9
Frankfurt am Main 9
Shenzhen 9
Dearborn 8
Fuzhou 8
Los Angeles 8
Taiyuan 8
Verona 8
Ningbo 7
Bari 6
Falkenstein 6
Frankfurt Am Main 6
Palermo 6
The Hague 6
Chicago 5
Falls Church 5
Lappeenranta 5
Nuremberg 5
Sasso Marconi 5
Xi'an 5
Totale 7.957
Nome #
Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis 506
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 202
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. 195
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate 166
Exosome-like Nanovesicles Isolated from Citrus limon L. Exert Antioxidative Effect 159
V-ATPase is a candidate therapeutic target for Ewing sarcoma 156
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 155
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 154
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. 154
In vitro blockade of Receptor Activator of Nuclear factor kappa b ligand prevents osteoclastogenesis induced by neuroblastoma cells 151
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation 150
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 147
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism 144
The Effects of Systemic and Local Acidosis on Insulin Resistance and Signaling 142
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis 141
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 140
V-ATPase as an effective therapeutic target for sarcomas. 137
Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells 136
Cause and effect of microenvironmental acidosis on bone metastases 133
The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells 132
MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases 131
The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation 131
Prominent role of RAB39A-RXRB axis in cancer development and stemness 131
Histogenetic characterization of giant cell tumor of bone 129
Identification and validation of housekeeping genes for gene expression analysis of cancer stem cells 124
Insulin receptor isoforms are differently expressed during human osteoblastogenesis. 123
Cathepsin k antisense inhibition of cell polarization and bone resorption in human osteoclast 122
Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. 122
New advances in the study of bone tumors: A lesson from the 3D environment 122
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. 120
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles 119
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. 118
Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion 118
In vitro study of human osteoclast activity on poli(epsilon-caprolactone) as a bone substitute biomaterial 117
Elevated serum activity of TRACP5B in osteosarcoma patients (OS) is associated with an aggressive phenotype and with OS induced osteoclast activity 117
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma 116
The human tumor microbiome is composed of tumor type-specific intracellular bacteria 116
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. 115
The effect of extracellular acidosis on the behaviour of mesenchymal stem cells in vitro 114
Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer 112
Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates 111
Energy metabolism in osteoclast formation and activity 111
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. 111
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Adaptations and Targets in Cancer 111
Spontaneous Formation of Multinucleated Giant Cells with Bone Resorbing Activity by Long Culture of Human Peripheral Blood CD14-Positive Monocytes In Vitro. 111
Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts. 109
Mesenchymal stroma: Role in osteosarcoma progression 109
In vitro effects of an antisense oligonucleotide targeting fgf-2 on renal carcinoma cells metastasizing to bone 108
Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target 108
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. 107
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas 107
Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. 107
IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. 105
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. 105
The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors. 104
3d printing and bioprinting to model bone cancer: The role of materials and nanoscale cues in directing cell behavior 104
The Effect of Poly(d,l-Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast Precursors. 103
Serum markers of loosening in patients with THA 101
Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy. 101
Role of IGF-IR in osteoclast biology and differentiation 100
Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells 100
Metabolism and microenvironment in cancer plasticity 100
Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood. 99
Acid microenvironment in bone sarcomas 99
Pre-clinical Models for Studying the Interaction between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness 98
Mesenchymal stromal cell adhesion and proliferation on ion-irradiated and RGD-modified polymer substrates 97
Cytoskeletal disorganization in human osteoclasts following cathepsin K down-regulation 94
Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells 93
in vitro effects of interferon-alpha on different cellular elements existing in a bone metastasis of renal cell carcinoma 92
MET overexpression turns human primary osteoblasts into osteosarcomas. 92
Therapeutic implications of tumor interstitial acidification 91
Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed msc in an in vitro model of osteosarcoma 91
Sustained Autocrine Induction and Impaired Negative Feedback of Osteoclastogenesis in CD14(+) Cells of Giant Cell Tumor of Bone 90
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study. 89
Height and pathogenesis of osteosarcoma 87
Stromal cells derived from giant cell tumor of bone show an osteoblastic phenotype and lack neoplastic features 86
Study on the in vitro effect of platelet rich plasma on bone endothelial cells and on osteoclast differentiation for maxillo-facial surgery 85
Stromal cells derived from giant cell tumor of bone show osteoblast-like feature 85
Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells 85
Isolation and characterization of a new cell line from a renal carcinoma bone metastasis 83
Photodynamic Surgery for Feline Injection-Site Sarcoma 83
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 83
Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2. 82
null 81
Elevated serum TRACP 5B levels and outcome in osteosarcoma patients 78
Unravelling the Effect of Citrate on the Features and Biocompatibility of Magnesium Phosphate-Based Bone Cements 78
Contribution of mitochondrial activity to doxorubicin-resistance in osteosarcoma cells 76
Background and rationale of platelet gel in orthopaedic surgery 76
Elevated serum activity of TRACP5b in osteosarcoma patients is associated with an aggressive phenotype 75
IGF-IR and osteoclast activity in skeletal metastases of neuroblastoma 73
Sarcoma treatment in the era of molecular medicine 73
Interferon-alpha as an anti-osteolityc drug for the treatment of bone metastases of renal cell carcinoma 72
Perfused Platforms to Mimic Bone Microenvironment at the Macro/Milli/Microscale: Pros and Cons 71
Immunohistochemical evaluation of bone metastases 67
Tumour-specific metabolic adaptation to acidosis is coupled to epigenetic stability in osteosarcoma cells 66
Role of Pericellular Matrix in the Regulation of Cancer Stemness 65
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 62
Osteoclast activating ability and angiogenetic properties of renal carcinoma cell lines, both primitive and bone metastatic 61
Electrospun fibers coated with nanostructured biomimetic hydroxyapatite: A new platform for regeneration at the bone interfaces 60
The microfluidic trainer: Design, fabrication and validation of a tool for testing and improving manual skills 60
Totale 11.228
Categoria #
all - tutte 32.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.420 0 0 0 0 0 0 289 323 365 161 109 173
2020/20211.822 294 212 68 82 99 98 40 185 140 87 60 457
2021/20222.258 200 84 147 165 158 123 58 153 78 237 463 392
2022/20232.358 244 341 129 265 177 177 69 152 371 55 202 176
2023/2024659 81 111 57 51 50 131 27 33 16 54 31 17
2024/20251.757 90 438 216 248 566 199 0 0 0 0 0 0
Totale 12.097